Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
2.610
-0.010 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
New New Deal Worries
May 27, 2021
Nio is up 1.4% today on another round of Meme buying.
Via
Talk Markets
The Surprising Move Vir Stock Made After Winning Covid Drug Authorization
May 27, 2021
GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday.
Via
Investor's Business Daily
Exposures
COVID-19
Sterling At Five-Year High
May 25, 2021
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.
Via
Talk Markets
60 Biggest Movers From Yesterday
May 27, 2021
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...
Via
Benzinga
Worldwide Upbeat
May 21, 2021
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Another Tough Day For Markets
May 17, 2021
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”
Via
Talk Markets
CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results
May 14, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
Friday Of The Heavy Week
May 14, 2021
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today
Via
Talk Markets
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
May 14, 2021
AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter.
Via
Investor's Business Daily
AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript
May 13, 2021
ABCL earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AbCellera Reports Q1 2021 Business Results
May 13, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present Virtually at Berenberg Conference on May 18, 2021
May 11, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
May 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
May 06, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
Finns and Danes
May 05, 2021
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.
Via
Talk Markets
Merry Month of May
May 04, 2021
Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened.
Via
Talk Markets
AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials
May 04, 2021
AbCellera Biologics Inc (NASDAQ: ABCL) has announced that a second antibody from its collaboration with Eli Lilly and Co (NYSE: LLY), LY-CoV1404, ...
Via
Benzinga
Exposures
COVID-19
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
May 04, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
22 Stocks Moving in Monday's Pre-Market Session
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...
Via
Benzinga
AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals
April 29, 2021
From
AbCellera
Via
Business Wire
Tuesday Market Report
April 27, 2021
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.
Via
Talk Markets
London Cancel
April 26, 2021
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.
Via
Talk Markets
Exposures
COVID-19
Earth Day
April 22, 2021
Once again the exchanges are unsure if they want to go up or down.
Via
Talk Markets
AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
April 21, 2021
From
AbCellera
Via
Business Wire
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration
April 14, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.